Showing posts with label Spillover. Show all posts
Showing posts with label Spillover. Show all posts
Monday, October 19, 2009
Determinants of R&D diversification strategies in the drug industry: competition, rather than spillovers, matters
A Working Paper by Tatiana Plotnikova on Technology, Competition and the Time of Entry: Diversification Patterns in the Development of New Drugs
Subscribe to:
Posts (Atom)
-
Panel, Programme here , Video here .
-
LG Frankfurt am Main, 2-06 O 172/09 (verkündet am 13.05.2009). Lesenswertes aus der Begründung (meine Hervorhebungen): "Vorstellbare ...
-
IPOS, here . Circular 3/18 here .
-
FTC Hearings, Video here .
-
M. Sheehan, here .